(MRI). The latter procedure may also provide information on the activity of the tumor. Associated etiologic factors include thegermline mutation, estrogens, andsurgical trauma.22Desmoids occur most commonly in theperitoneal cavity(Figure 43-5) and may infiltrate locally, leading to small bowel, ...
Intrathoracic des- moid tumor: CT and MRI appearance. South Med J 1994; 87:1007-9.Winer-Muram HT, Bowman LC, Parham D. Intrathoracic desmoid tumor: CT and MRI appearance. South Med J 1994;87:1007-9.H. T. Winer-Muram, L. C. Bowman, and D. Parham, "Intratho- racic desmoid tumor...
韧带样纤维瘤(desmoid[ˈdesmɔɪd]fibromatosis[ˈfəɪbrəʊˈmætəsɪs],DF) Younger age and female gender had a propensity[prəˈpensəti]for local recurrence[rɪˈkʌrəns], suggesting that the biological ...
MRI features reliably predict the growth of residual or recurrent DTs post-ablation, with [+iT2] being the most accurate. Adding nodular enhancement to [+iT2] improved specificity without sacrificing accuracy. Key Points Question Post-ablation imaging of desmoids is challenging due to tumor heterog...
在这个年龄组中,考虑髋关节是否是患者症状的来源也很重要,因为所提到的疼痛相对常见。鉴别诊断还需要包括恶性肿瘤(骨肉瘤),因为MRI检查结果可能相似。 参考文献: 1. Gould CF, Ly JQ, Lattin GE Jr, Beall DP, Sutcliffe JB 3rd. Bone ...
英文: DESMOID TUMOR OF ABDOMINAL WALL中文: 腹壁韧带样纤维瘤 英文: The Treatment of Desmoid on Buttock in Children中文: 儿童臀部硬纤维瘤的治疗体会 英文: MRI diagnosis of the extraabdom desmoid tumor中文: 腹壁外韧带样瘤MRI诊断探讨 英文: DESMOID TUMOR OF THE NECK——AN ANALYSIS OF CASES中文: ...
Indications for this were tumor-related symptoms or failure of conventional treatment. Of those, five of them were available for MRI followup at 12 months or longer (mean, 18.2 months; range, 12鈥 23 months). The radiographic and clinical outcomes of five patients who had desmoid tumors ...
Intestinal obstruction is a frequently encountered entity in surgical practice. The signs & symptoms, many a times, are suggestive of the level of obstruction, making the diagnosis of obstruction evident. There are various causes of intestinal obstructio
The RINGSIDE pivotal Phase 2/3 study is a randomized global multi-center trial. Part A of the study is evaluating the efficacy, safety, tolerability, and tumor volume by MRI after 16 weeks of AL102 in patients with desmoid tumors. It enrolled 42 patients and is evaluating 3...
Key secondary and exploratory end points included objective response rate, duration of response , quality of life, tumor volume changes as assessed by MRI, and the incidence of adverse effects. Changes in patient-reported outcomes for pain, symptom burden, and physical and role fu...